CHFS:NSD-CHF Solutions, Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 5.40

Change

-0.10 (-1.82)%

Market Cap

USD 0.04B

Volume

0.33M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Brunei, Germany, Greece, Hong Kong, India, Israel, Italy, Palestine, Singapore, Spain, Switzerland, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-04-09 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

+16.81 (+2.92%)

USD45.56B 25.69 87.90
PODD Insulet Corporation

+2.57 (+0.90%)

USD18.40B 2,785.00 159.67
ABMD Abiomed, Inc

+4.06 (+1.23%)

USD14.62B 73.68 55.53
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
BRKR Bruker Corporation

+1.16 (+1.72%)

USD10.21B 66.02 32.46
IART Integra LifeSciences Holdings ..

+0.65 (+0.94%)

USD5.86B 44.25 24.70
TNDM Tandem Diabetes Care, Inc

-0.01 (-0.01%)

USD5.50B N/A N/A
SWAV ShockWave Medical, Inc

-0.98 (-0.71%)

USD4.60B N/A N/A
AHCO AdaptHealth Corp

+0.27 (+0.72%)

USD4.32B -99,999.99 96.44
SDC SmileDirectClub, Inc

+0.01 (+0.10%)

USD3.90B N/A N/A

ETFs Containing CHFS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.53% 5% F 8% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.53% 5% F 8% F
Trailing 12 Months  
Capital Gain -56.10% 3% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.10% 3% F 2% F
Trailing 5 Years  
Capital Gain -100.00% 2% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -100.00% 2% F N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -61.28% 2% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.28% 2% F N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.04% 68% D+ 40% F
Risk Adjusted Return -149.31% 2% F N/A N/A
Market Capitalization 0.04B 11% F 7% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 0.56 77% C+ 91% A-
Price/Book Ratio 2.37 89% B+ 61% D-
Price / Cash Flow Ratio -2.17 30% F 61% D-
EV/EBITDA 0.06 90% A- 97% A+
Management Effectiveness  
Return on Equity -173.00% 20% F 7% F
Return on Invested Capital -186.12% 14% F 4% F
Return on Assets -83.10% 6% F 2% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.06 95% A 95% A
Short Percent 2.11% 82% B- 64% D
Beta 1.34 40% F 38% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.